Erica L Mayer (Erica Mayer)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Topics

Epidermal Growth Factor Receptor

Tyrosine Kinase

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Antonio Giordano, Priya U Kumthekar, Qingchun Jin, Busem Binboğa Kurt, Siyang Ren, Tianyu Li, José Pablo Leone, Elizabeth A Mittendorf, Alyssa M Pereslete, Laura Sharp, Raechel Davis, Molly DiLullo, Nabihah Tayob, Erica L Mayer, Eric P Winer, Sara M Tolaney, Nancy U Lin
A phase II study of atezolizumab, pertuzumab, and high-dose trastuzumab for central nervous system metastases in patients with HER2-positive breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Dario Trapani, Erica L Mayer
What's the reality for CDK4/6 inhibitors: Clinical trials or real-world evidence? Cancer 129 (7) (2023)
Albert Grinshpun, Sara M Tolaney, Harold J Burstein, Rinath M Jeselsohn, Erica L Mayer
The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer. NPJ breast cancer 9 (1) (2023)
Dario Trapani, Erica L Mayer
What's the reality for CDK4/6 inhibitors: Clinical trials or real-world evidence? Cancer 129 (7) (2023)
Albert Grinshpun, Sara M Tolaney, Harold J Burstein, Rinath M Jeselsohn, Erica L Mayer
The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer. NPJ breast cancer 9 (1) (2023)
Dario Trapani, Erica L Mayer
What's the reality for CDK4/6 inhibitors: Clinical trials or real-world evidence? Cancer 129 (7) (2023)
Dario Trapani, Erica L Mayer
What's the reality for CDK4/6 inhibitors: Clinical trials or real-world evidence? Cancer (2023)
Priscilla Kaliopi Brastianos, Albert E Kim, Anita Giobbie-Hurder, Eudocia Q Lee, Nancy U Lin, Beth A Overmoyer, Patrick Y Wen, Lakshmi Nayak, Justine V Cohen, Jorg Dietrich, April Eichler, Rebecca S Heist, Ian Krop, Donald Lawrence, Jennifer Ligibel, Sara M Tolaney, Erica L Mayer, Eric Winer, Brittany Bent, Magali A de Sauvage, Nazanin Ijad, Juliana M Larson, Braxton Marion, Sally Nason, Naina Murthy, Sherry Ratcliff, Elizabeth J Summers, Maura Mahar, Helen A Shih, Kevin Oh, Daniel P Cahill, Elizabeth R Gerstner, Ryan J Sullivan
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results. Nature medicine (2023)
Nicholas C Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, Massimo Cristofanilli, Giampaolo Bianchini, Stephen K L Chia, Hiroji Iwata, Wolfgang Janni, Cynthia X Ma, Erica L Mayer, Jang-Yeon Park, Steven Fox, Xiaochun Liu, Sasha McClain, Francois-Clement Bidard
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1 -mutant breast cancer during first-line treatment. Future oncology (London, England) (2023)
Pfeiler Georg, Dominik Hlauschek, Erica L Mayer, Christine Deutschmann, Stephanie Kacerovsky-Strobl, Miguel Martin, Jane Lowe Meisel, Nicholas Zdenkowski, Sibylle Loibl, Marija Balić, Haeseong Park, Aleix Prat, Claudine Isaacs, Emilio Bajetta, Justin M Balko, Merixtell Bellet-Ezquerra, Judith M Bliss, Harold J Burstein, Fatima Cardoso, Hannes Fohler, Theodoros Foukakis, Karen A Gelmon, Matthew P Goetz, Tufia C Haddad, Hiroji Iwata, Jacek Jassem, Soo-Chin Lee, Barbro Linderholm, Maartje Los, Eleftherios P P Mamounas, Kathy D Miller, Patrick G Morris, Elisabetta Munzone, Einav Nili Gal-Yam, Alistair Ring, Lois E Shepherd, Christian F Singer, Christoph Thomssen, Ling Ming Tseng, Pinuccia Valagussa, Eric P Winer, Antonio C Wolff, Francesco Ravera, Jana Machacek-Link, Céline Schurmans, Xin Huang, Eric Gauthier, Christian Fesl, Amylou C Dueck, Angela M DeMichele, Michael Gnant, null null
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Felipe Batalini, Niya Xiong, Nabihah Tayob, Madeline Polak, Julia Eismann, Lewis C Cantley, Geoffrey I Shapiro, Viktor Adalsteinsson, Eric P Winer, Panagiotis A Konstantinopoulos, Alan D' Andrea, Elizabeth M Swisher, Ursula A Matulonis, Gerburg M Wulf, Erica L Mayer
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Fabrice Andre, Nofisat Ismaila, Kimberly H Allison, William E Barlow, Deborah E Collyar, Senthil Damodaran, Norah L Henry, Komal Jhaveri, Kevin Kalinsky, Nicole M Kuderer, Anya Litvak, Erica L Mayer, Lajos Pusztai, Rachel Raab, Antonio C Wolff, Vered Stearns
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (16) (2022)
Erica L Mayer, Christian Fesl, Dominik Hlauschek, Laura Garcia-Estevez, Harold J Burstein, Nicholas Zdenkowski, Viktor Wette, Kathy D Miller, Marija Balic, Ingrid A Mayer, David A Cameron, Eric P Winer, José Juan Ponce Lorenzo, Diana Lake, Gunda Pristauz-Telsnigg, Tufia C Haddad, Lois Shepherd, Hiroji Iwata, Matthew P Goetz, Fatima Cardoso, Tiffany A Traina, Dhanusha Sabanathan, Urs Breitenstein, Kerstin Ackerl, Otto Metzger Filho, Karin Zehetner, Kadine Solomon, Sarra El-Abed, Kathy Puyana Theall, Dongrui Ray Lu, Amylou C Dueck, Michael Gnant, Angela M DeMichele
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (5) (2022)
Ilana Schlam, Paolo Tarantino, Stefania Morganti, Filipa C Lynce, Dario Trapani, Erica L Mayer, Ana Christina Garrido-Castro, Ada Waks, Sara M Tolaney
Emerging Targeted Therapies for Early Breast Cancer. Drugs 82 (14) (2022)
Felipe Batalini, Doga C Gulhan, Victor Y Mao, Antuan V Tran, Madeline Polak, Niya Xiong, Nabihah Tayob, Nadine M Tung, Eric P Winer, Erica L Mayer, Stian Knappskog, Per Eystein Lønning, Ursula A Matulonis, Panagiotis A Konstantinopoulos, David B Solit, Helen H Won, Hans Petter Eikesdal, Peter J Park, Gerburg M Wulf
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Tal Sella, Pedro Exman, Siyang Ren, Taylor S Freret, Katherine E Economy, Wendy Y Chen, Heather A Parsons, Nancy U Lin, Beverly Moy, Nadine M Tung, Ann H Partridge, Nabihah Tayob, Erica L Mayer
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis. Breast cancer research and treatment 194 (3) (2022)
Robert M Stern, M Dror Michaelson, Erica L Mayer, Aric D Parnes, Annemarie E Fogerty, Ann Steward LaCasce, Ryan David Nipp
Dana-Farber Cancer Institute/Mass General Brigham Fellowship Response to the COVID-19 Pandemic. JCO oncology practice 17 (9) (2021)
Laura M Spring, Shealagh L Clark, Tianyu Li, Shom Goel, Nabihah Tayob, Elene Viscosi, Elizabeth Abraham, Dejan Juric, Steven J Isakoff, Erica L Mayer, Beverly Moy, Jeffrey G Supko, Sara M Tolaney, Aditya Bardia
Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer. NPJ breast cancer 7 (1) (2021)
Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga, William Fraser Symmans, Ben Ho Park, Brian L Burnette, Amye J Tevaarwerk, Sofia F Garcia, Karen Lisa Smith, Della F Makower, Margaret Block, Kimberly A Morley, Chirag R Jani, Craig Mescher, Shabana J Dewani, Bernard Tawfik, Lisa E Flaum, Erica L Mayer, William M Sikov, Eve T Rodler, Lynne I Wagner, Angela M DeMichele, Joseph A Sparano, Antonio C Wolff, Kathy D Miller
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)
Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga, William Fraser Symmans, Ben Ho Park, Brian L Burnette, Amye J Tevaarwerk, Sofia F Garcia, Karen Lisa Smith, Della F Makower, Margaret Block, Kimberly A Morley, Chirag R Jani, Craig Mescher, Shabana J Dewani, Bernard Tawfik, Lisa E Flaum, Erica L Mayer, William M Sikov, Eve T Rodler, Lynne I Wagner, Angela M DeMichele, Joseph A Sparano, Antonio C Wolff, Kathy D Miller
Reply to T. Shimoi et al and Y. Shimanuki et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Michael Gnant, Amylou C Dueck, Sophie Frantal, Miguel Martin, Hal J Burstein, Richard Greil, Peter Fox, Antonio C Wolff, Arlene Chan, Eric P Winer, Georg Pfeiler, Kathy D Miller, Marco Colleoni, Jennifer M Suga, Gabor Rubovszky, Judith M Bliss, Ingrid A Mayer, Christian F Singer, Zbigniew Nowecki, Olwen Hahn, Jacqui Thomson, Norman Wolmark, Kepa Amillano, Hope S Rugo, Guenther G Steger, Blanca Hernando Fernández de Aránguiz, Tufia C Haddad, Antonia Perelló, Meritxell Bellet, Hannes Fohler, Otto Metzger Filho, Anita Jallitsch-Halper, Kadine Solomon, Céline Schurmans, Kathy P Theall, Dongrui Ray Lu, Kathleen Tenner, Christian Fesl, Angela M DeMichele, Erica L Mayer, null null
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Siang-Boon Koh, Kenneth Ross, Steven Jay Isakoff, Nsan Melkonjan, Lei He, Karina J Matissek, Andrew Schultz, Erica L Mayer, Tiffany A Traina, Lisa Anne Carey, Hope S Rugo, Minetta C Liu, Vered Stearns, Adam Langenbucher, Srinivas Vinod Saladi, Sridhar Ramaswamy, Michael S Lawrence, Leif W Ellisen
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Anton Sebastian Becker, Rocio Perez-Johnston, Sona A Chikarmane, Melissa M Chen, Maria El Homsi, Kimberly N Feigin, Katherine M Gallagher, Ehab Y Hanna, Marshall Hicks, Ahmet T Ilica, Erica L Mayer, Atul B Shinagare, Randy Yeh, Marius E Mayerhoefer, Hedvig Hricak, Hebert Alberto Vargas
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel. Radiology 300 (2) (2021)
Heather A Parsons, Justin Rhoades, Sarah C Reed, Gregory Gydush, Priyanka Ram, Pedro Exman, Kan Xiong, Christopher C Lo, Tianyu Li, Mark Fleharty, Gregory J Kirkner, Denisse Rotem, Ofir Cohen, Fangyan Yu, Mariana Fitarelli-Kiehl, Ka Wai Leong, Melissa E Hughes, Shoshana M Rosenberg, Laura C Collins, Kathy D Miller, Brendan Blumenstiel, Lorenzo Trippa, Carrie Cibulskis, Donna S Neuberg, Matthew DeFelice, Samuel S Freeman, Niall J Lennon, Nikhil Wagle, Gavin Ha, Daniel G Stover, Atish D Choudhury, Gad A Getz, Eric P Winer, Matthew Meyerson, Nancy U Lin, Ian Krop, J Christopher Love, G Mike Makrigiorgos, Ann H Partridge, Erica L Mayer, Todd R Golub, Viktor A Adalsteinsson
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Brian D Lehmann, Vandana G Abramson, Melinda E Sanders, Erica L Mayer, Tufia C Haddad, Rita Nanda, Catherine Van Poznak, Anna Maria Storniolo, Julie R Nangia, Paula I Gonzalez Ericsson, Violeta Sanchez, Kimberly N Johnson, Richard G Abramson, Sheau-Chiann Chen, Yu Shyr, Carlos L Arteaga, Antonio C Wolff, Jennifer A Pietenpol, null null
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (9) (2019)
Jennifer M Giltnane, Katherine E Hutchinson, Thomas P Stricker, Luigi Formisano, Christian D Young, M Valeria Estrada, Mellissa J Nixon, Liping Du, Violeta Sanchez, Paula I Gonzalez Ericsson, Maria G Kuba, Melinda E Sanders, Xinmeng Jasmine Mu, Eliezer Van Allen, Nikhil Wagle, Ingrid A Mayer, Vandana Abramson, Henry Gόmez, Monica Rizzo, Weiyi Toy, Sarat Chandarlapaty, Erica L Mayer, Jason Christiansen, Danielle A Murphy, Kerry Fitzgerald, Kai Wang, Jeffery S Ross, Vincent A Miller, Phillip J Stephens, Roman Yelensky, Levi Garraway, Yu Shyr, Ingrid Meszoely, Justin M Balko, Carlos L Arteaga
Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance. Science translational medicine 9 (402) (2018)